Navigation Links
Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*
Date:3/24/2009

ANTONY, France, March 24 /PRNewswire-FirstCall/ -- Stallergenes S.A. and Solvay Pharmaceuticals Marketing and Licensing AG (subsidiary of Solvay Group) announce the signing of an exclusive partnership agreement for the promotion and distribution of Stallergenes diagnostic and treatment products in Russia and the Commonwealth of Independent States (CIS).

With an estimated 20 million allergy sufferers and a strong demand on the part of the medical community for quality products, the Russian market represents a real opportunity for Stallergenes.

The main products in Stallergenes' injectable and sublingual ranges will soon be the subject of registration applications. This partnership will enable Stallergenes to meet more than 80% of the needs of allergy sufferers in Russia and the CIS by 2011.

"We're delighted to be teaming up with Solvay Pharmaceuticals to target the potential growth this new market represents. Thanks to its franchise and its considerable expertise recognized by allergy specialists, Solvay Pharmaceuticals will enable us to promote the desensitization standardized products, and notably the sublingual route, and their benefits for patients," declared Albert Saporta, Stallergenes' Chairman and CEO.

"We're tremendously enthusiastic about the prospect of collaborating with the world leader in sublingual desensitization therapy and making its innovative standardized products available to practitioners," emphasizes Mr. Jens Neuschaefer, Vice President, Regional Director, Solvay Pharmaceuticals.

*countries concerned: Russia, Georgia, CIS (Commonwealth of Independent States: Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldavia, Uzbekistan, Russia, Tajikistan, Turkmenistan, and Ukraine).

About Stallergenes' International Development

Today, Stallergenes markets its products in more than 50 different countries, via 11 subsidiar
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
2. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
3. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
4. Stallergenes Inaugurates the Biggest Pharmaceutical Allergen Production Unit in the World
5. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
6. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
7. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
8. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
9. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
10. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
11. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , NOVATO, Calif., Nov. 30 /PRNewswire-FirstC...N ) announced today that the Food and Drug Adminis...for 3,4-diaminopyridine (3,4-DAP), amifampridine p...Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has pre...U. Also, in October 2009, the Committee for Medic...
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewsw...announced today that the Harvard Medical School IC...ecognized as a MicroRNA Screening Center of Excell...dical School, and associated hospitals and institu...cule and RNAi libraries. ,, MicroRNAs are a nov...
(Date:11/30/2009)... , AMSTERDAM, N... world,s,leading publisher of scientific, medical ...ed a major re-launch of Embase, its comprehensive ...dexed records from more than 7,000,active, peer re... a key role in the advancement of new biomedical,a...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 /PRNewswire/ ... will initiate water-soluble carbon nanotube-based...The water-soluble carbon nanotubes, which have fun...ation with cancer drugs, was developed in partners... conjugated carbon nanotubes serves as a drug deli...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...Call/ -- China Technology,Development Group Corpor...rovider of clean and renewable energy products and...ina, today is pleased to announce that it has,appo...") to act as its,independent auditor for the fisca...ry of the service term of Friedman LLP ("Friedman"...
...asdaq: MDVN ) today reported on its financial res...mber 31, 2007., "In 2007 we continued our track r...ent across our entire portfolio, and we are please...t candidate in confirmatory,Phase 3 development," ...utive officer of Medivation. "We remain committed ...
...of Pulse CO-Oximetry as a way to, protect the li...of CO Poisoning, IR...inventor of Pulse CO-Oximetry and Measure-Through ... today that the National Fire Protection,Associati...ing by Pulse,CO-Oximetry as part of a new national...
Other Biology Technology:China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor 2Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 2Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 3Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 4Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 5Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 6Medivation Reports Year-End 2007 Financial Results and Pipeline Progress 7National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 2National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 3National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 4
(Date:11/30/2009)...iversity researchers Ron Falta and Larry Murdoch h...Agency grant to study the safe storage of carbon d... the earth,s surface. , With carbon dioxide emis... leading cause of global warming, geologic storage...ves for reducing emissions using current technolog...
(Date:11/30/2009)...9) Scientists and engineers from two of the natio...come together Dec. 7 with leading academicians to ...ood. , Much like moving oil through a pipeline, ...systems need clean, well-functioning pipes (or blo...nction efficiently. Both industries also are cruci...
(Date:11/30/2009)...er early bird registration rates and register onli...010 at http://www.iofwco-ecceo10.org/ , WHAT:...ational Osteoporosis Foundation (IOF) and the Euro...Osteoporosis and Osteoarthritis (ESCEO). More than...cted to attend. The exciting scientific programme ...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Pelosi Remarks Following House Democrats Meeting with President Obama 60895 1Pelosi Remarks Following House Democrats Meeting with President Obama 60895 2PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 60893 1PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 60893 2PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 60893 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks Give Patients Time to Start Therapy and Decrease Morbidity 6069 1Prodromal Symptoms Warn of Hereditary Angioedema Attacks Give Patients Time to Start Therapy and Decrease Morbidity 6069 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks Give Patients Time to Start Therapy and Decrease Morbidity 6069 3
...niversity of Sheffield has shown that major oil sp... impact on populations of British sea birds than w...Tim Birkhead from the Department of Animal and Pla...for the first time that major oil spills double th...ven though the pollution occurs hundreds of miles ...
...k CNS infectionA single molecular anchor that allo...the key to treating many types of bacterial mening... School of Medicine study has found. , By blockin...y be able to find a way to stave off the most comm... and a major cause of childhood death and disabili...
...uel disease. Left untreated, prostate cancer cells...form fracture-prone tumors that are extremely pain...rostate cancer die with metastatic disease in thei... migrating prostate cancer cells set up housekeepi...ns characteristic of prostate cancer. , Now, new ...
Other Biology News:Oil spills and climate change double the mortality rate of British seabirds 2Researchers identify molecular anchor that allows bacterial invasion of central nervous system 2Researchers identify molecular anchor that allows bacterial invasion of central nervous system 3Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 2Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 3
...ease III digests duplex DNA in a 3'-> 5' direction...stretches of single-stranded DNA. Under defined re...III proceeds at a uniform rate yielding predictabl...onucleolytic excision of deoxyribonucleotides by E...
RNase H from Roche Applied Science
Goat Anti-Human Haptoglobin Polyclonal Antibody, Unconjugated from Abcam
Rat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: